S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.07%) $0.927
USD/NOK
(0.19%) $10.86
USD/GBP
(-0.03%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for Sino Biopharmaceutical [1177.HK]

Exchange: HKSE Sector: Pharmaceuticals Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-03-29)

Expected move: +/- 0.00%

Last Updated28 Mar 2024 @ 04:08

0.33% HKD 3.02

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China...

Stats
Today's Volume 32.72M
Average Volume 49.27M
Market Cap 55.57B
EPS HKD0 ( 2023-08-25 )
Next earnings date ( HKD0 ) 2024-03-29
Last Dividend HKD0.0600 ( 2023-06-20 )
Next Dividend HKD0 ( N/A )
P/E 27.45
ATR14 HKD0.0100 (0.33%)

Volume Correlation

Long: -0.12 (neutral)
Short: 0.19 (neutral)
Signal:(44.934) Neutral

Sino Biopharmaceutical Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sino Biopharmaceutical Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.45
( neutral )

Sino Biopharmaceutical Financials

Annual 2022
Revenue: HKD28.78B
Gross Profit: HKD22.98B (79.86 %)
EPS: HKD0.270
Q3 2023
Revenue: HKD0
Gross Profit: HKD0 (0.00 %)
EPS: HKD0
Q2 2023
Revenue: HKD7.64B
Gross Profit: HKD6.01B (78.68 %)
EPS: HKD0.0339
Q1 2023
Revenue: HKD7.64B
Gross Profit: HKD6.01B (78.68 %)
EPS: HKD0.0339

Financial Reports:

No articles found.

Sino Biopharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0600
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0600
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Sino Biopharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.15 - Stable (2.90%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.00198 2004-09-16
Last Dividend HKD0.0600 2023-06-20
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 70 --
Total Paid Out HKD0.573 --
Avg. Dividend % Per Year 0.00% --
Score 4.04 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.15
Div. Directional Score 7.79 --
Next Divdend (Est)
(2024-04-22)
HKD0 Estimate 4.21 %
Dividend Stability
0.34 Poor
Dividend Score
4.04
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3877.HK Ex Dividend Knight 2023-06-28 Semi-Annually 0 0.00%
1763.HK Ex Dividend Knight 2023-07-04 Annually 0 0.00%
0811.HK Ex Dividend Knight 2023-05-22 Annually 0 0.00%
2333.HK Ex Dividend Junior 2023-06-29 Annually 0 0.00%
1319.HK Ex Dividend Knight 2023-08-02 Semi-Annually 0 0.00%
0388.HK Ex Dividend Knight 2023-08-29 Semi-Annually 0 0.00%
6119.HK Ex Dividend Junior 2023-06-06 Annually 0 0.00%
1881.HK Ex Dividend Junior 2023-05-11 Semi-Annually 0 0.00%
0914.HK Ex Dividend Junior 2023-06-02 Annually 0 0.00%
0052.HK Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07111.5008.5810.00[0 - 0.5]
returnOnAssetsTTM0.02391.2009.2010.00[0 - 0.3]
returnOnEquityTTM0.05261.500-0.527-0.791[0.1 - 1]
payoutRatioTTM0.404-1.0005.96-5.96[0 - 1]
currentRatioTTM1.0040.8009.987.98[1 - 3]
quickRatioTTM0.8480.8009.727.77[0.8 - 2.5]
cashRatioTTM0.4311.5008.7210.00[0.2 - 2]
debtRatioTTM0.176-1.5007.07-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.1962.009.9310.00[0 - 30]
freeCashFlowPerShareTTM0.1422.009.9310.00[0 - 20]
debtEquityRatioTTM0.385-1.5008.46-10.00[0 - 2.5]
grossProfitMarginTTM0.7881.0000.1970.197[0.2 - 0.8]
operatingProfitMarginTTM0.2031.0007.947.94[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3311.0009.279.27[0.2 - 2]
assetTurnoverTTM0.3360.800-1.092-0.873[0.5 - 2]
Total Score10.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.961.0006.570[1 - 100]
returnOnEquityTTM0.05262.50-0.339-0.791[0.1 - 1.5]
freeCashFlowPerShareTTM0.1422.009.9510.00[0 - 30]
dividendYielPercentageTTM2.841.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.1962.009.9310.00[0 - 30]
payoutRatioTTM0.4041.5005.96-5.96[0 - 1]
pegRatioTTM0.3621.500-0.9200[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1741.0008.160[0.1 - 0.5]
Total Score5.15

Sino Biopharmaceutical

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators